A strategy of using moderate statin therapy and adjusting until a target low-density lipoprotein cholesterol (LDL-C) level of 50 to 70 mg/dL was achieved was noninferior to a high-intensity statin regimen at 3 years in patients with coronary artery disease (CAD), new randomized trial results show.